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Introduction
　The technology of tissue engineering, which was 
established by Langer and Vacanti1, involves the 
morphogenesis of new tissue using constructs 
formed from isolated cells with scaffolds and 
growth factors.  The creation of induced pluripo-
tent stem (iPS) cells2 in 2007 has accelerated 
research in the ﬁeld of stem cell-based regenera-
tive medicine.  However, the clinical use of iPS 
cells and embryonic stem (ES) cells involves both 
safety problems and ethical concerns.  These prob-
lems can be reduced through the use of somatic 
stem cells, such as mesenchymal stem cells 
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Abstract : Tissue engineering and bone regeneration techniques using mesenchymal stem cells 
(MSCs) have started to be applied to the ﬁeld of oral and maxillofacial surgery.  Clinically, a short-
ened treatment time and improved efﬁciency are necessary because of the patients' needs and the 
running cost of cell culture.  In the present study, the cultivation process for human MSCs (hMSCs) 
was examined by regulating the Wnt signaling pathway.  We activated Wnt signaling with LiCl 
and inhibited Wnt signaling with sFRP-3 (secreted Frizzled-Related Protein-3).  The proliferation 
of LiCl-treated hMSCs was examined by studying the cell growth rate and performing BrdU as-
says.  Osteogenic differentiation of sFRP-3-treated hMSCs was examined by alizarin red staining, 
and osteogenic gene expression on days 7 and 14 after induction was examined by reverse-tran-
scription polymerase chain reaction (RT-PCR) analysis and quantitative real-time RT-PCR analy-
sis.  LiCl-treated hMSCs showed increased cell numbers and BrdU-positive cells as compared to 
the untreated cells.  Alizarin red staining showed early mineralization of hMSCs on day 7 of the 
sFRP-3 treatment.  A high expression level of the alkaline phosphatase gene on days 7 and 14 of 
sFRP-3 treatment was also demonstrated.  These results suggest that the regulation of the Wnt 
signaling pathway contributes to the increased cell numbers and the early osteogenic differentia-
tion of hMSCs.  This study supports the possibility that the regulation of the Wnt signaling path-
way contributes to the development of effective and efﬁcient bone regeneration techniques.
Key words : mesenchymal stem cells (MSCs), regenerative medicine, bone, Wnt signaling, secreted 
frizzled-related protein-3 (sFRP-3)
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(MSCs).  MSCs can be easily obtained from bone 
marrow or other sites, and their pluripotent nature 
allows them to replicate while undifferentiated and 
then differentiate into lineages of mesenchymal 
tissue including bone, cartilage, fat and muscle3.
　In the ﬁeld of oral and maxillofacial surgery, 
including dental implant surgery, autogenous 
bone grafts are considered to be the gold standard 
for the treatment of bone defects.  This well-stud-
ied procedure has a good prognosis, but it requires 
an extra surgical procedure at the donor site, 
which is an additional burden on the patient. 
Although allografts, xenografts, and alloplasts are 
commercially available, these materials tend to be 
easily infected and induce antigenic responses. 
Therefore, the establishment of a novel bone 
regeneration technique is needed to replace the 
conventional bone graft method.
　Bone marrow MSCs have great potential for 
bone regeneration, and clinical applications of 
MSCs are under way.  In previous studies, we 
used MSCs as isolated cells and platelet-rich 
plasma (PRP) as the source of growth factors and 
scaffolds for bone regeneration, and we succeeded 
in forming bone in the grafted area4.  However, 
the clinical application of growth factors such 
as BMP-25 and ﬁbroblast growth factor-26 has 
revealed some problems, including limitations to 
the amount of bone that can be regenerated. 
Therefore, new methods for bone regeneration 
should be investigated.
　Wnt is a large family of secreted signaling mole-
cules that play a number of important roles during 
animal development processes7.  The canonical 
Wnt signaling pathway is the Wnt-β-catenin 
pathway, which regulates cytoplasmic β-catenin, 
leading to the downstream transcription of Wnt 
target genes8.  Reya et al. ﬁrst revealed the rela-
tionship between stem cells and Wnt signaling; 
they showed that the canonical Wnt pathway was 
involved in the self-renewal of haematopoietic 
stem cells9.  Moreover, the canonical Wnt pathway 
has been implicated in bone formation.  Since the 
osteoporosis-pseudoglioma syndrome has an inac-
tivating mutation in the Wnt co-receptor LRP5 
(low-density lipoprotein receptor-related protein 
5)10,11, the canonical pathway is considered to be 
the key regulator of osteogenesis.  In the absence 
of Wnt signals, β-catenin is phosphorylated by 
GSK-3β (glycogen synthase kinase-3β) and then 
degraded by proteosomes.  In the presence of 
Wnt signals, Wnt receptors, which are frizzled 
homologs, activate the phosphoprotein Dishev-
elled, and the ability of GSK-3β to phosphorylate 
β-catenin is then inhibited.  Unphosphorylated β- 
catenin is stable and accumulates in the cytosol 
and nucleus.  In the nucleus, β-catenin binds to 
T-cell factor (TCF)/lymphocyte enhancer-binding 
factor (LEF) to form a functional transcription fac-
tor, which mediates the transactivation of target 
genes8.
　Wnt signals play an important role in the pro-
liferation and differentiation of human MSCs 
(hMSCs).  Wnt 3a, a canonical Wnt member, 
induces the proliferation of MSCs and β-catenin 
nuclearization, and inhibits the osteogenic differ-
entiation of MSCs.  A low concentration of the Wnt 
mimic lithium, which inhibits phosphorylation of 
β-catenin by GSK-3β, also stimulates hMSC pro-
liferation12-14.  On the other hand, sFRP-3 (secreted 
Frizzled-related protein-3), which is a secreted 
Wnt inhibitor, is upregulated during the osteogen-
esis of MSCs12.  However, these effects of Wnt sig-
naling have not been incorporated into the con-
ventional methods of hMSC cell culture.  The reg-
ulation of Wnt signals has the potential to acceler-
ate the proliferation and osteogenic differentiation 
of cultured hMSCs.  This acceleration would be 
clinically beneﬁcial, because it would shorten the 
treatment time, improve the treatment efﬁciency, 
and reduce the running cost of cell culture.
　In the present study, we investigated the effects 
of LiCl and sFRP-3 on two aspects of the behavior 
of hMSCs in vitro, proliferation and differentia-
tion.  We hope to establish a more efﬁcient culture 
process for hMSCs, which would contribute to the 
future of regenerative medicine of bone.
Materials and Methods
　Cell culture
　We used commercially available primary mar-
row-derived hMSCs (Lonza, Walkersville, MD). 
hMSCs were cultured at 37℃ in a 5％ CO2 atmo-
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sphere.  MSCGM, which consists of MSCBM (basal 
medium) and SingleQuotsⓇ (Mesenchymal Cell 
Growth Supplement, L-glutamine and penicillin/
streptomycin; Lonza), was used as the growth 
medium, according to the manufacturer's protocol. 
We used hMSC Differentiation BulletKit-Osteo-
genic (Lonza) as the osteogenic induction medium. 
This medium contains dexamethasone, ascorbate, 
Mesenchymal Cell Growth Supplement, L-glu-
tamine, penicillin/streptomycin, and β-glycero-
phosphate.  The medium was refreshed every 
three days.
　We used a 400 mM stock solution of lithium 
chloride (LiCl) (Sigma, St. Louis, MO) diluted in 
MSCGM.  Recombinant human sFRP-3 (R&D Sys-
tems, Minneapolis, MN) was used at a concen-
tration of 10 ng/ml in the osteogenic induction 
medium.
　For growth rate analysis, 30,000 cells were 
plated onto a 35-mm tissue culture dish.  Dishes 
were then trypsinized on days 3, 6, 9 and 12, and 
triplicate cell counts were performed visually with 
the use of a hemacytometer.  The proliferation 
rate of subconﬂuent cultures was assessed by bro-
modeoxyuridine (BrdU) incorporation for 24 h 
using a Zymed BrdU staining kit (Invitrogen, 
Carlsbad, CA).
　Immunoﬂuorescent antibody staining
　Cells grown on cover slips were ﬁxed with PBS 
containing 4％ paraformaldehyde for 15 min and 
then rendered permeable with PBS containing 
0.1％ Triton X-100 for 3 min at 4℃.  After blocking 
with 2％ bovine serum albuminutes in PBS for 30 
min, the cells were incubated with anti-β-catenin 
mouse monoclonal antibody (BD Biosciences, San 
Jose, CA) diluted 1 :500 in blocking solution at 4℃ 
overnight.  Then, the cells were washed and incu-
bated with a 1 :150 dilution of goat anti-mouse 
secondary antibody conjugated to rhodamine 
(Leinco Technologies, St. Louis, MO).  To visualize 
the bound antibody, we washed the cells and incu-
bated them with 60 ng/ml of DAPI (Roche, India-
napolis, IN) diluted in ethanol.
　Alizarin red staining
　To detect the calcium depositions of hMSCs, the 
induced cells were washed with PBS and ﬁxed 
with 95％ ethanol for 10 min.  Then, the cell cul-
tures were washed ﬁve times with distilled water 
and stained with a 2％ solution (pH 6.4) of Aliza-
rin Red S (Sigma) for 5 min.  PBS was then added 
for 15 min to reduce the intensity of staining.
　RNA isolation and reverse transcription-
polymerase chain reaction (RT-PCR)
　On days 7 and 14 after osteogenic induction, 
cells were removed from the culture dish with 
scrapers, and total RNA was prepared from the 
cells using an RNeasy Mini Kit (Qiagen, Valencia, 
CA).  To analyze the expression level of mRNA 
encoding type I collagen, alkaline phosphatase, 
Runx-2, osteocalcin and GAPDH, total RNA (10 
ng) was subjected to RT-PCR analysis with the 
Titan One Tube RT-PCR System (Roche Molecular 
Biochemicals, Mannheim, Germany).  Speciﬁc 
primers are listed in Table 1.  RT-PCR was per-
formed with 25 ampliﬁcation cycles, according to 
the manufacturer's protocol.  The reaction prod-
ucts were analyzed on a 2％ agarose gel and 
stained with ethidium bromide.
　Quantitative real-time reverse transcrip-
tion-polymerase chain reaction (real-time RT-
PCR)
　RNA (100 ng) was subjected to reverse transcrip-
tion using TaqMan EZ RT-PCR Core Reagents 
(Applied Biosystems, Foster City, CA), according 
to the manufacturer's instructions.  Real-time RT-
PCR was performed in an ABI PRISM 7000 
Sequence Detector System (Applied Biosystems) 
with the speciﬁc primers and probes listed in 
Table 1.  The GAPDH primer and probe (TaqMan 
GAPDH detection reagents) were purchased from 
Perkin-Elmer and Applied Biosystems.  Cycling 
conditions were 2 min at 50℃, 30 min at 60℃, 5 
min at 95℃ and 50 cycles for 20 sec at 95℃, 1 min 
at 60℃.
　Relative mRNA expression levels were normal-
ized to GAPDH expression, and the data from 
sFRP-3-treated samples were also normalized 
with the data from the samples without sFRP-3 
treatment.
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　Statistical analysis
　All experiments were performed at least three 
times.  The paired Student's t test was used to 
analyze the data, and p＜ 0.05 was considered to 
be statistically signiﬁcant.
Results
　1.  Effect of LiCl and sFRP-3 on hMSC pro-
liferation
　To investigate the effect of Wnt signaling activa-
tion by LiCl on hMSC proliferation, we compared 
the proliferation of LiCl-treated cells to the prolif-
eration of a control GM group, which was cultured 
in MSCGM only.  We analyzed cell number to 
assess proliferation and performed BrdU assays 
to assess DNA synthesis.  Compared to the GM 
group, the hMSCs cultured with 4 mM LiCl had 
an increased cell number, but the proliferation of 
the hMSCs cultured with 20 mM or 40 mM LiCl 
was strongly inhibited (Fig. 1A).  Compared to the 
GM group, the cells cultured with 4 mM LiCl had 
a statistically signiﬁcant increase in the number 
of BrdU-positive cells ; however, culture with 20 
mM or 40 mM LiCl yielded a statistically signiﬁ-
cant decrease in the number of BrdU-positive cells 
(Fig. 1B).  Results from the BrdU assay were con-
sistent with those from the growth rate analysis.
　We also investigated the effect of sFRP-3, a Wnt 
inhibitor, on hMSCs proliferation.  hMSCs treated 
with 10 ng/ml sFRP-3 had a statistically signiﬁ-
cant reduction in proliferation as compared to the 
control GM group (Fig. 1A, B).
　2.  Effect of LiCl on β-catenin localization 
in hMSCs
　Immunoﬂuorescent antibody staining against 
cellular β-catenin was performed to detect the 
localization of β-catenin in hMSCs (Fig. 2).  In the 
control group, β-catenin was localized to the cyto-
plasm and rarely found in the nucleus (Fig. 2A-C). 
In the 4 mM LiCl group, β-catenin was localized 
to both the cytoplasm and nucleus (Fig. 2D-F); 
interestingly, intense reactions to β-catenin were 
seen around the nucleus.  In the 40 mM LiCl 
group, β-catenin was found both in the cytoplasm 
and nucleus (Fig. 2G-I).  The intense reaction 
around the nucleus seen in the 4 mM group was 
not prominent, and the nuclear β-catenin was 
markedly increased in the 40 mM group compared 
to that in the 4 mM group.
　3.  Effect of sFRP-3 on the osteogenic differ-
entiation of hMSCs
　Alizarin red staining was performed on hMSCs 
that were cultured for 7 or 14 days in osteogenic 
induction medium with or without 10 ng/ml 
sFRP-3 (Fig. 3A, B).  On day 7, more calciﬁcation 
was seen in the sFRP-3-treated hMSCs than in 
the hMSCs without sFRP-3.  This tendency was 
Table 1　Speciﬁc primers and probes used in RT-PCR and real-time RT-PCR
Primer Sequence Genbank ID
Col I (F)GTGACCGGGGCGAAGCTG NM000089
(R)ACCGACCTCACCACGTTCAC
(Probe) TGGTCCTGCTGGTCCTGCTGGTCC
ALP (F)AGAAAGCCAGGGGCACGAG NM000478
(R)GGGAGTGCTTGTATCTCGGTTTG
(Probe)CCTGGACCTCGTTGACACCTGGAAGAGC
Runx2 (F)GCATGTCCCTCGGTATGTCC NM004348
(R)GGTCCACTCTGGCTTTGGG
(Probe)ACCACTCACTACCACAACCTACCTGCCAC
OC (F)AGAGTCCAGCAAAGGTGCAG NM000711
(R)CCCAGCCATTGATACAGGTAGC
(Probe)CTTCACTACCTCGCTGCCCTCCTGCT
Col I : Type I collagen, ALP: alkaline phosphatase, OC: osteocalcin
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more prominent on day 14, and the calciﬁcation 
increased rapidly in the sFRP-3-treated hMSCs.
　Gene expression of type I collagen, alkaline 
phosphatase, Runx2 and osteocalcin was also ana-
lyzed on days 7 and 14.  RT-PCR analysis showed 
high expression levels of the alkaline phosphatase 
Fig. 1　 Effect of LiCl and sFRP-3 on hMSC proliferation.
(A) Growth rate analysis. Proliferation of hMSCs was accelerated with the addition of 4 mM LiCl (4 mM group) compared 
with the GM group. In the 20 mM and 40 mM groups, hMSC proliferation was strongly inhibited. Addition of sFRP-3 (GM/
sFRP-3 group) suppressed the proliferation of hMSCs. (B) BrdU-positive cells were statistically increased in the 4 mM group 
but statistically decreased in the 20 mM and 40 mM groups compared with the GM group. In the GM/sFRP-3 group, reduced 
cell proliferation of hMSCs was shown. Error bars represent S.D. from three experiments. The asterisks indicate signiﬁcant 
difference from the control GM group (p＜ 0.05).
Fig. 2　  Immunocytochemistry for β-catenin.
 (A-C) hMSCs cultured in basal medium (MSCGM). (D-F) hMSCs cultured with 4 mM LiCl. Cytoplas-
mic and nuclear β-catenin (arrow). (G-I) hMSCs cultured with 40 mM LiCl. Intense localization of β- 
catenin in the nucleus (arrow). Scale bar ＝ 200 μm
42 Oral Science International　Vol. 7, No. 2
gene in the sFRP-3-treated hMSCs on days 7 and 
14.  On days 7 and 14, Type I collagen and Runx2 
gene expression was seen regardless of sFRP-3 
treatment, while osteocalcin gene expression 
was relatively weak (Fig. 4).  The expression level 
of alkaline phosphatase mRNA on day 7 was 
increased in sFRP-3-treated hMSCs compared 
to hMSCs cultured without sFRP-3 (Fig. 5A). 
On day 14, the expression level of alkaline phos-
phatase mRNA tended to be higher in the sFRP-3-
treated hMSCs compared to the untreated cells 
(Fig. 5B).
Discussion
　Bone regeneration with hMSCs will provide 
minimally invasive techniques, by eliminating the 
need for surgery at the donor site.  Furthermore, 
this technique does not create any ethical prob-
lems, and the patient's safety is guaranteed by the 
use of their own autogenous cells.  These advan-
tages will contribute to increased quality of life for 
the patient.  However, there are problems associ-
ated with hMSC-based regenerative medicine. 
The cultivation of hMSCs is expensive and time-
consuming.  Moreover, there are differences in cell 
Fig. 3　 Alizarin red staining of sFRP-3-treated hMSCs in osteogenic differentiation.
(A) During osteogenic induction of hMSCs, more calciﬁcation occurred in the hMSCs 
treated with sFRP-3 than in the non-treated cells on days 7 and 14. (B) Phase-contrast 
microscopic view (× 40).
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proliferation among patients.
　Although Wnt signaling is involved in regulat-
ing the proliferation and differentiation potential 
of hMSCs12,13, the application of Wnt signaling to 
optimize culture conditions for hMSCs has not 
previously been addressed.  In the present study, 
we investigated how to more efﬁciently cultivate 
hMSCs for clinical use by utilizing the character-
istics of Wnt signaling, which regulates the pro-
liferation of hMSCs and negatively regulates the 
differentiation of hMSCs.
　Boland et al. revealed that Wnt 3a exposure 
inhibits hMSC osteogenic and adipogenic differ-
entiation and promotes cell proliferation12.  It was 
also reported that a high concentration of LiCl 
promoted the alkaline phosphatase activity and 
changed the cell appearance, while a low con-
centration of LiCl decreased the alkaline phos-
phatase activity and promoted the proliferation of 
hMSCs13,14.
　In the present study, we investigated the effect 
of LiCl on the proliferation of hMSCs by examin-
ing their cell number and BrdU incorporation. 
While the addition of 4 mM LiCl promoted the 
proliferation of hMSCs compared with hMSCs cul-
tured in MSCGM only, high concentrations of 
LiCl (20 or 40 mM) inhibited the proliferation of 
Fig. 4　 RT-PCR analysis.
Gene expression of type I collagen (Col I), alkaline phos-
phatase (ALP), Runx2 and osteocalcin was analyzed on 
days 7 and 14 after osteogenic induction. RT-PCR analysis 
showed a high expression level of the ALP gene in the sFRP-
3-treated hMSCs both on days 7 and 14. There were no ob-
vious differences in the expression levels of the other genes.
Fig. 5　 Real-time RT-PCR analysis.
(A) The ALP expression level in sFRP-3-treated hMSCs was increased on day 7 compared to that in 
untreated hMSCs. (B) On day 14, there was a tendency for the ALP expression level to be increased in 
sFRP-3-treated hMSCs compared to untreated hMSCs. Relative mRNA expression levels were normal-
ized to GAPDH expression. The data from sFRP-3-treated samples were also normalized with the data 
from the samples without sFRP-3 treatment. Error bars represent the S.D. from three experiments. 
The asterisks indicate signiﬁcant differences from the control GM group (p＜ 0.05).
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hMSCs.  Immunocytochemistry against nuclear β- 
catenin indicated that Wnt signaling was acti-
vated in a dose-dependent manner.  A high concen-
tration (40 mM) of LiCl caused a strong reaction 
against nuclear β-catenin but inhibited prolifera-
tion.  The BrdU assay supports this dose-depen-
dent effect of LiCl and is consistent with the data 
on population doubling of LiCl-treated hMSCs 
reported by de Bore et al.13  High concentrations 
of LiCl inhibit hMSC proliferation and cause 
cytoskeletal rearrangement.  Our preliminary stud-
ies also showed the rearrangement of actin ﬁla-
ments and alterations in the shape of hMSCs from 
spindle to cuboidal, but the dose-dependent inhi-
bition of hMSC proliferation by Wnt 3a condi-
tioned medium has not been reported until now. 
As the inhibition of GSK3β kinase activity by 
LiCl is thought to regulate the cytoskeletal Tau 
protein15,16, de Boer et al. inferred that the dose-
dependent inhibition of hMSC proliferation by 
LiCl might occur in a Wnt-independent manner13.
　In previous studies, Wnt 3a-conditioned culture 
medium was collected from a murine L cell line 
that was stably transfected with Wnt 3a and used 
to activate Wnt signaling in vitro.  However, many 
problems such as safety for using the product of 
the other animal must be overcome before Wnt 3a 
can be used clinically.  LiCl, however, has been used 
clinically for decades as an effective drug for bipo-
lar disorder17.  When activating Wnt signaling in 
hMSC culture for clinical use, there are fewer 
problems associated with LiCl than with Wnt 
3a-conditioned culture medium.  Moreover, LiCl is 
not an expensive drug ; thus, it may contribute not 
only to shortening the culture time but also to 
reducing the cost of culturing hMSCs.  The effects 
of LiCl on hMSCs are reversible16, and LiCl does 
not affect the pluripotency of hMSCs13.  Our pre-
liminary study also showed that hMSCs treated 
with 4 mM LiCl could differentiate into an osteo-
genic lineage (data not shown).
　Among the clinical applications of osteogenic 
differentiated hMSCs, the effects of Wnt signaling 
have not been considered.  Wnt signaling inhibits 
the osteogenic differentiation of hMSCs in vivo12. 
If we establish a new method of cell culture that 
reduces the negative effect of Wnt signaling, 
the efficient osteogenic induction of hMSCs can 
be achieved.  In the present study, we used the 
secreted Wnt inhibitor sFRP-3 to downregulate 
Wnt signaling and investigated how the osteogenic 
differentiation of hMSCs could be regulated.
　We found that sFRP-3 suppressed hMSC prolif-
eration, increased early calciﬁcation and increased 
the expression level of the alkaline phosphatase 
gene 7 days after the initiation of osteogenic 
induction.  On day 14, the calciﬁcation of sFRP-3-
treated hMSCs was more prominent, and the 
alkaline phosphatase gene expression was more 
increased compared to that of untreated hMSCs. 
The promotion of the osteogenic differentiation of 
hMSCs with sFRP-3 implies that Wnt signaling 
somewhat inhibits the osteogenic induction under 
conventional culture methods, but inefﬁciently.
　sFRP-3 is a member of the family of soluble pro-
teins that are structurally related to the Wnt 
receptors, Frizzled proteins.  sFRPs are recognized 
as decoy receptors that bind to Wnt proteins to 
prevent signal activation18.  sFRP-1 causes loss of 
bone mass in adult mice by inhibiting Wnt-β- 
catenin signaling in osteoblasts.  sFRP-1－/－ 
mice exhibited an increased trabecular bone min-
eral density, volume and mineral apposition rate 
compared with sFRP-1＋/＋ controls19.  Oshima et 
al. reported that human multiple myeloma cell 
lines constitutively produced sFRP-2 at the pro-
tein level and that bone formation was suppressed 
at least in part through the inhibition of Wnt 
signaling via the secretion of sFRP-220.  Thus, the 
sFRP families are related to bone formation and 
act competitively with Wnt signaling.
　However, contrary to these previous reports, the 
present study showed that the inhibition of Wnt 
signaling by sFRP-3 promoted the osteogenic dif-
ferentiation of hMSCs.  There are some differences 
in the effects of Wnt signaling among different cel-
lular backgrounds and cell origins.  For example, 
Wnt signaling activates alkaline phosphatase in 
C3H/10T1/2 cells from mouse embryos21, but 
Wnt signaling inactivates alkaline phosphatase in 
hMSCs12,13.  Thus, the effects of Wnt signaling on 
cell proliferation and differentiation are cell-type 
speciﬁc, and little is known about the responsible 
mechanisms.  However, Boland et al. showed that 
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the gene expression of alkaline phosphatase and 
bone sialoprotein was downregulated in hMSCs 
osteogenically induced with Wnt 3a but upregu-
lated in hMSCs osteogenically induced with Wnt 
3a and sFRP-312.  This result indicates that Wnt 
signaling is a negative regulator of osteogenic dif-
ferentiation of hMSCs and that sFRP-3 activates 
osteogenic differentiation, which is consistent with 
the results of the present study.  Although the 
effects of Wnt signaling are cell speciﬁc, the tar-
gets are the same.  The targets are the osteogenic-
related genes such as alkaline phosphatase and 
bone sialoprotein.  Gaur et al. demonstrated by 
mutational analysis that a functional TCF regula-
tory element responsive to canonical Wnt signal-
ing resides in the prompter of the Runx2 gene; 
they suggested that the canonical Wnt signaling 
pathway directly regulated Runx2 and that it was 
a target of β-catenin/TCF1 for the stimulation of 
bone formation22.  In the present study, the gene 
expression of alkaline phosphatase was upregu-
lated on day 7, and the gene expression of Runx2 
remained relatively high on day 14.  However, 
sFRP-3 treatment did not affect the gene expres-
sion of osteocalcin, while more calciﬁcation was 
seen in sFRP-3 treated cells.  The discrepant 
results between calciﬁcation and the gene expres-
sion of osteocalcin in sFRP-3 treated hMSCs 
might arise from the stage of calciﬁcation.  The 
gene expression of osteocalcin gene is known to be 
upregulated at the late stage of osteoblast devel-
opmental sequence23.  Our study focused on the 
early stage of osteogenic differentiation of hMSCs 
and the gene expression of osteocalcin gene did 
not seem to be upregulated at such an early stage. 
However, the gene expression of Runx2 gene was 
relatively high on day 14 and Runx2 is known as 
a positive regulator that can upregulate the 
expression of osteocalcin24, so the gene expression 
of osteocalcin is expected to be upregulated at the 
late stage of osteogenic differentiation of sFRP-3 
treated hMSCs.  From this point of view, our 
results indicate that Wnt signaling can affect the 
early stage of osteogenic differentiation of hMSCs.
　Careful investigations are required when we 
consider animal studies, because the effects of 
Wnt signaling may be cell-type speciﬁc.  Recently, 
it has been reported that Wnt 5a, which is thought 
to be part of the non-canonical Wnt pathways, 
regulates cell proliferation and osteogenic differ-
entiation and affects the canonical Wnt pathway25. 
Potential cross-talk between the canonical and 
non-canonical Wnt signaling pathways was also 
reported26.  Future studies should clarify the com-
plexities of Wnt signaling in hMSCs.
　The present study revealed the possibilities of 
efﬁcient cell culture of hMSCs for regenerative 
bone medicine by regulating Wnt signaling.  In 
other words, regulation of Wnt signaling promoted 
cell proliferation without the use of any growth 
factors and accelerated the osteogenic differenti-
ation of hMSCs.  These results will contribute to 
future regenerative bone medicine by decreasing 
the time and expense of cell culture and by pro-
ducing better quality regenerated bone.
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